Four years into its strategic plan, the Measles & Rubella Partnership's Midterm Review reveals that while progress has been made, countries and global institutions must take urgent, collective action to reach elimination targets by 2030. At the end of 2024, 83 countries had eliminated measles a...

Dear Colleagues, I just published a concise analysis of Nepal’s rubella elimination through the WUENIC 2024 lens. It outlines the operating model behind the milestone, a 2024 coverage snapshot with visuals. It closes with a practical maintenance checklist for programs aiming to sustain elimination...

🛡️ When Should We Conduct a Measles-Rubella Vaccination Campaign? (Latest WHO Global Guidance) 🌍 GIS can be the game changer! As a Surveillance & Immunization Medical Officer, I often get asked: ❓ “When is the right time for a Measles-Rubella (MR) campaign?” Here’s my field-tested, WHO-aligne...

Background The dissemination of the interim guidance is intended for national immunization programme managers, campaign decision-makers and global, regional and country-level policy-makers and partners responsible for the design, implementation, monitoring and evaluation of measles and rubella vacc...

HISP Rwanda et l'Université d'Oslo ont le plaisir de vous inviter à la prochaine Académie DHIS2 en français sur les outils d’analyse, Niveau 1 qui se tiendra du 21 au 26 août 2023 à l'hôtel Galaxy de Kigali, au Rwanda. L'Académie sur les outils d'Analyse donne l'opportunité de comprendre les princi...

Dear colleagues,  The conclusions of the Global Measles and Rubella Strategic Plan 2012–2020 implementation midterm review highlighted the need to update protocols for guiding surveillance and outbreak investigation and response.  To that end, WHO and partners have developed the ...

Dear Colleagues, I would like to bring to your attention that the Summary Tables of WHO Routine Immunization Recommendations have been updated. The latest versions (November 2021) of the Summary Tables (available in both FRENCH and ENGLISH) can be downloaded from the WHO website (htt...

Many thanks for attending the session on measles and rubella microarray patches. Follow the URL below to see the session in case you have missed it:  https://www.youtube.com/watch?v=wAcQx5SI6c8 Below I summarise key discussion points from the session:  • The few remaining countries that...

Greetings, everyone. I hope that you are healthy and keeping your spirits up amidst these trying times. In March this year, just before COVID-19 shutdowns, I visited health facilities in Kinshasa - where mothers were being asked to wait (one for over 2 hours) and turned away for measles vaccination...

We have MR Vaccine for a campaign that had to be suspended due to current COVID-19 circumstances. These vaccines had been stored between minus 15 and minus 25 deg C at the Primary Store. Later, Vaccines were supplied to the District stores where they had been stored between plus 2 and 8 deg C. We w...

Dear TechNet members, please find below a link to a new WHO-UNICEF publication related to the ongoing COVID-19 pandemic that you may find useful. Immunization in the context of the COVID-19 pandemic: FAQs https://apps.who.int/iris/handle/10665/331818 The document will be translated and the links ...

Dear measles and rubella vaccine delivery and implementation experts, WHO is soliciting your expertise on the potential need and use for microarray patches (MAPs) (otherwise known as microneedles or microneedle patches) to deliver measles and rubella vaccines (MR), particularly in the context of ex...

Dear viewrs of techNet community We wish to share the attached wherein a planning unit lead by AYUSH Lady Medical Officer has attained and sustained >95% FIC below one year and DPT 1st booster with OPV and MCV/MRCV. We feel proud to share this as it is attached to our Medical College.  Quo...

Dear Technet 21 Community, We are glad to share the Measles and Measles-Rubella (MR) Vaccine Five-dose vial presentations Facts sheet. This Facts Sheet informs of the availability of Measles vaccine and combined Measles-Rubella (MR) vaccine in both a 10-dose vial and a 5-dose vial presentations th...

Hello everyone, Mozambique, at present, uses only a simple measles vaccine in the Measles Routine for measles prevention.However, with support from GAVI, Mozambique is preparing a campaign against Measles and Rubella for April 2018, then introducing the Measles and Rubella Vaccine into Routine Immu...

Planning and Implementing High-Quality Supplementary Immunization Activities for Injectable Vaccines Using an Example of Measles and Rubella Vaccines- Field Guide: This is a field guide that is intended for immunization programme managers and their partners. The focus of this guide is ensuring high...

Dear all We are presenting this post for inputs from the viewers which will help us in critically reviewing the programme as an exercise for the post graduates. This may indierectly help in reaching the goals and objectives of GVAP by 2020. Context: Government of India (GOI) has launched Mission ...

Dear viewers “Measles & Rubella (MR) case based surveillance” is being launched to achieve the goals of measles elimination and rubella control. For any vaccine preventable disease, vaccinating routinely with potent vaccine, uniformly throughout the country following a standard schedule is mandator...

Every quarter, a slide set on introduction status of selected vaccines is updated. The most recent version is available from the web @: http://www.who.int/immunization/monitoring_surveillance/en/ in the right hand column, under the “recent immunization data” menu. If you want to see the worldwi...

The updated Updated Standard Operating Procedure (SOP) to request M&RI funding to respond to measles outbreaks in Gavi eligible countries are available at: http://www.measlesrubellainitiative.org/wp-content/uploads/2014/02/SOP_MRI_Outbreak_Response_Fund_June2014_Final.pdf or at http:/...